Anupam Rasayan India reported 37.11% decline in consolidated net profit to Rs 30.62 crore on 25.04% fall in revenue from operations to Rs 293.96 crore in Q2 FY25 over Q2 FY24.

We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a ...

Onyx Biotec Ltd. (OBL), a pharmaceutical company specializing in sterile water for injections, is making its debut on the ...

The report shows strong growth in Asian markets, with India at 8.8% CAGR, followed by China (8.7%) and South Korea (8.6%).

The yield has risen 73.6 basis points over the past seven weeks, according to Dow Jones Market Data. On Friday, traders were ...

Analyst Naz Rahman from Maxim Group reiterated a Buy rating on scPharmaceuticals (SCPH – Research Report) and keeping the price target at ...

Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

Pharma and biotech stocks are down due to concerns over Robert F. Kennedy Jr. possibly taking the helm at HHS. Read more here ...

Wall Street is absorbing a jump in retail sales and Jerome Powell's hawkish comments as Trump-fueled optimism starts to wear ...

The event organised by Informa Markets in India, will be one-stop destination for innovative, cost-effective solutions for ...

The latest GDP figures come as a blow to Rachel Reeves, the chancellor, who said she was not "satisfied with the numbers".